Index

Pulmonary and Critical Care Division Publications

• 2011

• 2012

• 2013

• 2014

• 2015

Books

Abstracts

Manuscripts Pulmonary and Critical Care Division Publications

2011

1. Panselinas E, Polychronopoulos V, Judson MA. Acute Pulmonary Exacerbations of Sarcoidosis. In: Acute Exacerbation of respiratory Diseases. Sahn SA, ed. Jaypee Brothers Medical Publishers, New Delhi, India. 2011. pp. 97-113.

2. Konduru S, Koussa G, Naber M, Beegle, S. Recurrent sepsis in a 69-year-old woman. Chest 2011; 140:1091-1094.

3. Farkas JD, Amery S, Napier MB, Alderisio WG, Almond JG, Hellwitz FJ. A 74-year-old man with an incidental right-sided pleural effusion” Chest 2011; 139:1232-1236

4. Yarmus L, Feller-Kopman D, Lechtzin N, Napier MB, Dressel D, Van der Kloot T. A Randomized Prospective Trial of the Utility of Rapid On-Site Evaluation of Transbronchial Needle Aspirate Specimens. Journal of Bronchology & Interventional Pulmonology. 18:121-127, 2011

2012

1. Trapnell BC, McColley SA, Kissner DG, Rolfe MW, Rosen JM, McKevitt M, Moorehead L, Montgomery AB, Geller DE; for the Phase 2 FTI study group. Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients with Pseudomonas Airway Infection. Am J Respir Crit Care Med. 2012; 185:171-178.

2. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: A comprehensive review and update for the dermatologist. Part 1: Cutaneous disease. J Amer Acad Dermatol 2012; 66:699e1-e18

3. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: A comprehensive review and update for the dermatologist. Part 2: Extracutaneous disease. J Amer Acad Dermatol 2012; 66:719e1- e10

4.Nozaki K, Judson MA. Neurosarcoidosis: Clinical manifestations, diagnosis and treatment. La Presse Medicale La Presse Medicale 2012; 41:e331-e348

5.Forrest GP, Smith TC, Triolo RJ, Gagnon J, Dirisio D, Miller ME, Rhodi L. Use of the Case Western Reserve/Veterans Administration neuroprosthesis for exercise, standing, and transfers by a paraplegic subject. Disabil Rehabil Assist Technol 2012; 7:340-344

6. Bains SN, Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med 2012; 33:265-281

7. Judson MA. The treatment of pulmonary sarcoidosis. Respir Med 2012; 106:1351-1361

8. Panselinas E, Judson MA. Acute pulmonary exacerbations of sarcoidosis (APES). Chest 2012; 142:827-836

9. Baughman RP, Drent M, Culver DA, Grutters JC, Handa T, Humbert M, Judson MA, Lower EE, Mana J, Pereira CA, Prasse A, Sulica R, Valyere, D, Vucinic V, Wells AU. Endpoints for clinical trials of sarcoidosis. Sarcoidosis, Vasc Diff Lung Dis 2012; 29:90-98 2013

1. Kalkanis AG, Judson MA. Distinguishing asthma from sarcoidosis: An approach to a problem that is not always solvable. J Asthma 2013; 50:1-6

2. Asghar Pasha M, Smith TC, Feustel PJ, Jourd'heuil D. Effect of low-dose fluticasone proprionate/salmeterol combination therapy on exhaled nitric oxide and nitrite/nitrate breath condensates form patients with mild persistent asthma. J Asthma 2013; 50:64-70

3. Judson MA. Sarcoidosis. Conn’s Therapy. Bope ET, Kellerman RD eds. Saunders Elsevier Philadelphia, PA, 2013 pp 378-381

4. Okuezue BA, Haqqie SS, Foulke LA, Napier M, Vachharajani T, Matthew RO, Phelps K, Merrill D, Asif A. Mediastinal-renal syndrome: A rare manifestation of granulomatosis with polyangiitis. Open Urol Nephrol J, 2013; 6:20-25

5. Kalkanis A, Yucel R, Judson MA. The internal consistency of PRO fatigue instruments in sarcoidosis: Superiority of the PFI over the FAS. Sarcoidosis Vasc, Diff Lung Dis. (in press)

6. Beegle SH, Barba K, Gobunsuy R, Judson MA.Current and emerging pharmacological treatments of sarcoidosis: A review. Drug Des Devel Ther 2013:7; 325-338

7. Patel A, Sun JH, Kim I, Jones D, Richter S, Green J, Judson MA. GI tract sarcoidosis: A review. Pract Gastroenterol J 2013; 37:25-38

8. Yager NM, Ghate K, Swan RL, Farrokh A, Barba K, Beegle SH. A rare case of empyema. Chest 2013; 144:350-353

9. Medarov BI, Victorson DE, Judson MA. Patient reported outcome (PRO) measures for sleep disorders and related problems: Clinical and research applications. Chest (in press)

10. Judson MA, Shapiro L, Freitas S, Polychronopoulos VS, Highland KB. Concomitant sarcoidosis and a connective tissue disease: Review of the clinical findings and postulations concerning their association. Respiratory Medicine 2013; 1453-1459

11. Kalkanis AG, Kalkanis DG, Polychronopoulos VS, Judson MA. Case Report: Detection of sarcoidosis associated fasciitis by uptake on a FDG PET scan: A novel finding. Sarcoidosis, Vasc, Diff Lung Dis 2013; 30:143-145

12. Nozaki K, Judson MA. Neuorsarcoidosis. Curr Treat Options Neurol. 2013; 15:492-504

13. Judson MA. The diagnosis of sarcoidosis. In: Pulmonary Sarcoidosis: A Guide for the Practicing Clinician, Judson MA Ed. Springer, New York. pp. 1-18

14. Panselinas E, Judson MA. Acute pulmonary exacerbations of sarcoidosis (APES). In: Pulmonary Sarcoidosis: A Guide for the Practicing Clinician, Judson MA Ed. Springer, New York. Pp. 65-78

15. Butterfield JM, Lodise TP, Beegle S, Rosen J, Farkas J, Pai MP. Pharmacokinetics and pharmacodynami9cs of once-daily administration of intravenous tobramycin in adult patients with cystic fibrosis hospitalized for an acute exacerbation. Antimicrob Ag Chemother 2013; 57:5175- 5177

16. Cerniglia, B, Judson MA. Infliximab-induced hypothyroidosis: A novel case and postulations concerning the mechanism. Case Rep Med 2013; 216939

17. Kalkanis A, Judson MA, Napier MB. Pneumocystis Jerovecii pneumonia in an untreated chronic lymphocytic leukemia patient: a novel case and postulations concerning the mechanism. Br Med J Case Reports [Nov. 28, 2013] doi:10.1136/bcr-2013 202124

2014

1. Butterfield JM, Lodise TP, Beegle S, Rosen J, Farkas J, Manjunath PP. Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations. J Antimicrobial Chemother 2014; 144:350-353

2. Judson MA, Baughman RP, Costabel U, Mack M, Barnathan ES. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial. Respir Med 2014; 108:189- 194

3. Judson MA. Sarcoidosis. Conn’s Therapy. Bope ET, Kellerman RD eds. Saunders Elsevier Philadelphia, PA, 2014 pp 384-386

4. Baughman RP, Judson MA. Relapses of sarcoidosis: What are they and can we predict who will get them? Eur Respir J (Editorial) 43:337-339

5. Judson MA, Costabel U, Drent M, Wells A. Maier L, Koth L, Culver DA, Gelfand J, Valyere D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, The WASOG Sarcoidosis Organ Assessment Investigators. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diff Lung Dis 2014; 31:19-27

6. Judson MA, Baughman RP. How many organs need to be involved to diagnose sarcoidosis? An unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diff Lung Dis (Editorial) 2014; 31:6-7

7. Medarov BI, Chopra A, Judson MA. Clinical aspects of portopulmonary hypertension. Respir Med 2014; 108:943-954

8. Barna B, Judson MA, Thomassen M. Carbon Nanotubes and Chronic Granulomatous Disease. Nanomaterials 2014; 4:508-521

9. Birnie DH, Sauer W, Bogun F, Cooper J, Culver DA, Duvernoy C, Judson MA, Kron J, Mehta D, Nielsen JC, Patel AR, Ohe T, Raatikainen P, Soejima K. HRS expert concensus statement on the diagnosis and management of arrythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11:1304-1323

10. Medarov BI. Dyspnea. In: The Art and Science of Palliative Medicine. Smith HS, Pilitsis JG, Eds. AME Publishing Company, Hong Kong. pp. 290-297

11. Medarov BI. End stage lung disease. In: The Art and Science of Palliative Medicine. Smith HS, Pilitsis JG, Eds. AME Publishing Company, Hong Kong. pp. 121-130

12. Judson MA, Baughman RP. Wosening of pulmonary sarcoidosis. Curr Opin Pulm Med 2014: 20:508- 516

13. Pereira CA, Dornfeld MC, Baughman R, Judson MA. Clinical phenotypes in sarcoidosis. Curr Opin Pulm Med 2014; 20:496-502 14. Judson MA. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep. 2014, 6:89 : DOI: 10.12703/P6-89. http://f1000.com/prime/reports/m/6/89

15. Judson MA, Chaudhry H, Compa DR, O’Donnell AE. A Delphi study of pharmacotherapy for non-cystic fibrosis bronchiectasis. Am J Med Sci 2014; 348:387-393

16. Eisen L, Doelken P. Ultrasound Evaluation of the Pleura. Levitov A, Mayo PH, Slonim A: Critical Care Ultrasonography. New York: McGraw Hill, 2014

17. Doelken P, Mayo PH. Ultrasound-Guided Transthoracic Procedures. Levitov A, Mayo PH, Slonim A: Critical Care Ultrasonography. New York: McGraw Hill, 2014

18. Huggins JT, Doelken P. Pleural Ultrasound Interpretation. Soni NJ, Arntfield R, Kory P: Point-of- Care Ultrasound. Philadelphia: Elsevier, 2014

19. Huggins JT, Doelken P. Lung and Pleural Procedures. Soni NJ, Arntfield R, Kory P: Point-of-Care Ultrasound. Philadelphia: Elsevier, 2014

20. Subedi R, Judson MA. Chronic hypoxemia and paraganglioma: A rare case and discussion of potential mechanisms. Am J Med Sci 2014; 348:528-529

21. Crouser E, Judson MA. Procedings of the 2014 AASOG Conference. (Editorial) Sarcoidosis Vasc Diff Lung Dis 31:369-363

2015

1. Judson MA. Determining the cause of pulmonary granulomas: A multi-dimensional process. (Editorial). Respirology. 2015; 20:5-6

2 Judson MA. Sarcoidosis. Conn’s Therapy. Bope ET, Kellerman RD eds. Saunders Elsevier, Philadelphia, PA, 2015 pp 408-411

3. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis PD, Pappas PG. T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial. Clin Infect Dis 2015; 60:892-899

4. Judson MA, Chaudhry H, Louis A, Lee K, Yucel R. The Effect of Corticosteroids on Quality of Life in a Sarcoidosis Clinic: The results of a propensity analysis. Respir Med 2015; 109:526-531 Books

1. Judson MA., Editor. Pulmonary Sarcoidosis: A Guide for the Practicing Physician. Springer. New York. 2013

Abstracts

1. Choudry SA, Rashid NT, Patel MB, Foulke L, Blinkhorn RJ, Judson MA. Iatrogenic Kaposi’s Sarcoma. New York State Thoracic Society Meeting, Valhalla, New York. 2-1-13 ***Dr. Patel was the sole winner of the fellows case report poster session (approximately 25 posters) at this meeting.

2. Rashid NT, Patel MB, Gobunsuy R, Choudry SA, Foulke L, Judson MA. Cavitary lesions and emphysema. New York State Thoracic Society Meeting, Valhalla, New York. 2-1-13

Manuscripts in press

1. Judson MA. The Clinical Features of Sarcoidosis: A Comprehensive Review. Clinical Rev Allergy Immunol (in press)

2. Hamzeh N, Steckman D, Sauer W, Judson MA. Pathophysiology and Clinical Management of Cardiac Sarcoidosis. Nature Rev Cardiol (in press)

3. Medarov BI, Judson MA. The role of calcium channel blockers for the treatment of PAH: How much do we actually know? Respir Med (in press)